Physician Assistant Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

William Havens

Physician Assistant, Medical Bloomington, IN Physician Assistant

NPI 1831182898 CMS profile 11159502

1200 S Rogers St, Bloomington, IN 47403

Open in the dashboard

General payments

$2,742

127 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Havens of Bloomington, IN is reported in the CMS Open Payments database as having received $2,742 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,768 87
2024 General $974 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Havens
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to William Havens were reported at $1,768. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year William Havens Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $0 $156 $41–$563 $132
2022 $0 $185 $55–$649 $149
2023 $0 $199 $58–$717 $160
2024 $974 $206 $62–$740 $164
2025 $1,768 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Sun Pharmaceutical Industries Inc. $548 17 payments
  2. Janssen Biotech, Inc. $448 22 payments
  3. UCB, Inc. $346 16 payments
  4. Novartis Pharmaceuticals Corporation $316 14 payments
  5. Amgen Inc. $239 12 payments
  6. AbbVie, Inc. $185 15 payments
  7. Incyte Corporation $123 5 payments
  8. Regeneron Healthcare Solutions, Inc. $92 4 payments
  9. LEO Pharma Inc. $68 4 payments
  10. Galderma Laboratories, L.P. $65 2 payments
  11. Other $311 16 payments

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Food and Beverage $2,260 122 payments
  2. Education $482 5 payments
Products named General payments · program years 2024–2025
  1. TREMFYA $448 22 payments
  2. Bimzelx $346 16 payments
  3. ILUMYA $253 14 payments
  4. Otezla $239 12 payments
  5. COSENTYX $186 9 payments
  6. OPZELURA $123 5 payments
  7. RINVOQ $109 10 payments
  8. SKYRIZI $77 5 payments
  9. NEMLUVIO $65 2 payments
  10. DUPIXENT $56 3 payments
  11. Other $584 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record